Circulating tumor cell levels and carcinoembryonic antigen: An improved diagnostic method for lung adenocarcinoma.
Cheng DingXiaofei ZhouChun XuJun ChenShen JuTengfei ChenZhipan LiangZihan CuiChang LiJun ZhaoPublished in: Thoracic cancer (2018)
The detection of CTCs can be used as a biomarker for screening SPNs and diagnosing early-stage lung cancer. Using the combination of CTC levels and CEA significantly improves the efficacy of lung adenocarcinoma diagnosis.